You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,729,667


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,729,667 protect, and when does it expire?

Patent 10,729,667 protects NAFTIN and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 10,729,667
Title:Topical compositions and methods for making and using same
Abstract: The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.
Inventor(s): Hardas; Bhushan (Summerville, NC), Dalton; Donna (High Point, NC), Scheppler; Petra (Mainz, DE), Buch; Anja (Eschborn, DE), Boderke; Peter (Schwalbach, DE)
Assignee:
Application Number:16/195,153
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,729,667: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, patent holders, and legal professionals. This article will delve into the specifics of United States Patent 10,729,667, exploring its claims, scope, and the broader patent landscape it operates within.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of protection granted to the inventor. They must be clear, concise, and well-defined to avoid issues of indefiniteness[5].

Independent and Dependent Claims

A patent typically includes both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. The clarity and consistency of these claims are critical for patent validity and enforcement[5].

The Scope of Patent 10,729,667

To analyze the scope of Patent 10,729,667, one must examine the independent claims and how they define the invention.

Claim Construction

Claim construction is a legal process that determines the meaning and scope of the claims. This is often a contentious issue, as different interpretations can significantly impact the patent's validity and infringement analysis. The Federal Circuit has emphasized that claim construction is a question of law, subject to de novo review on appeal[5].

Independent Claim Length and Count

Research has shown that metrics such as independent claim length and count can provide insights into the scope and quality of a patent. Narrower claims, as measured by these metrics, are often associated with a higher probability of grant and a shorter examination process[3].

Patent Landscape and Related Patents

Understanding the patent landscape involves looking at related patents, continuations, and continuations-in-part.

Continuations and Continuations-in-Part

Patents like those in the Cellect case illustrate how continuations and continuations-in-part can complicate the patent landscape. These types of patents can lead to issues with obviousness-type double patenting (ODP), where multiple patents covering the same invention but with different patent terms can arise[1].

Patent Term Adjustment (PTA) and Terminal Disclaimers

The USPTO's handling of Patent Term Adjustment (PTA) and terminal disclaimers is crucial. PTA can extend the term of a patent due to delays in the USPTO's processing, but it does not extend the term past the date of a terminal disclaimer, which is often used to overcome ODP rejections[1].

Obviousness-Type Double Patenting (ODP)

ODP is a significant concern in the patent landscape, particularly for patents that are part of the same family. It prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other factors[1].

Patent Quality and Scope

The quality and scope of patents are subjects of ongoing debate. Metrics such as claim length and count can help measure patent scope, and narrower claims are generally associated with higher patent quality. Broader claims can lead to increased licensing and litigation costs, potentially diminishing innovation incentives[3].

Inter Partes Review (IPR) and Patent Validity

The validity of patent claims can be challenged through inter partes review (IPR) proceedings. These proceedings, conducted by the Patent Trial and Appeal Board (PTAB), can determine the unpatentability of claims based on prior art and other grounds. The outcome of IPRs can significantly impact the scope and enforceability of a patent[5].

Role of the USPTO

The U.S. Patent and Trademark Office (USPTO) plays a central role in granting patents and ensuring their validity. The USPTO's processes, including the adjustment of patent terms and the handling of terminal disclaimers, are critical in maintaining the integrity of the patent system[2].

Expert Analysis and Court Decisions

In complex patent cases, expert analysis and court decisions can provide clarity. For example, the appointment of an independent expert to analyze claim terms can help resolve disputes over claim construction and validity[5].

Practical Implications for Inventors and Patent Holders

For inventors and patent holders, understanding the scope and claims of their patents is essential for enforcement and defense. Here are some key takeaways:

  • Clear Claim Drafting: Ensure that claims are clear, concise, and well-defined to avoid indefiniteness issues.
  • Patent Term Management: Understand how PTA and terminal disclaimers can impact the term of your patent.
  • ODP Considerations: Be aware of the potential for ODP issues, especially in patent families with multiple continuations and continuations-in-part.
  • IPR Preparedness: Be prepared to defend your patent claims in IPR proceedings by ensuring strong prior art searches and robust claim construction.

Key Takeaways

  • Patent Claims: Clear and well-defined claims are crucial for patent validity and enforcement.
  • Patent Scope: Metrics like independent claim length and count can help measure patent scope and quality.
  • ODP: Understanding ODP is vital for managing patent families and avoiding invalidation.
  • USPTO Processes: The USPTO's handling of PTA and terminal disclaimers is critical for maintaining patent term integrity.
  • IPR and Expert Analysis: Be prepared for IPR challenges and consider expert analysis for complex claim construction issues.

FAQs

Q: What is the significance of independent claims in a patent?

A: Independent claims define the invention and stand alone, while dependent claims further limit the independent claims. They are crucial for determining the scope of protection granted to the inventor.

Q: How does Patent Term Adjustment (PTA) impact the term of a patent?

A: PTA extends the term of a patent due to delays in the USPTO's processing but does not extend the term past the date of a terminal disclaimer.

Q: What is obviousness-type double patenting (ODP), and why is it important?

A: ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA or other factors.

Q: How do inter partes review (IPR) proceedings affect patent validity?

A: IPR proceedings can determine the unpatentability of claims based on prior art and other grounds, significantly impacting the scope and enforceability of a patent.

Q: Why is clear claim drafting important for patent holders?

A: Clear claim drafting avoids issues of indefiniteness, ensuring that the patent claims are valid and enforceable.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Claims and Patent Scope, SSRN, 2016.
  4. Invention, Knowledge Transfer, and Innovation, NCSES, 2022.
  5. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC., United States Court of Appeals for the Federal Circuit, 2024.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,729,667

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Ireland Ltd NAFTIN naftifine hydrochloride GEL;TOPICAL 204286-001 Jun 27, 2013 AB RX Yes Yes 10,729,667 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,729,667

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014212201 ⤷  Subscribe
Canada 2899725 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2014121048 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.